CN Patent

CN115298196A — 介白素-23受体的肽抑制剂及其治疗炎性疾病的用途

Assigned to Janssen Biotech Inc · Expires 2022-11-04 · 4y expired

What this patent protects

本发明提供介白素‑23受体的新颖肽抑制剂和相关组合物，以及使用这些肽抑制剂来治疗或预防多种疾病和病症，包括炎性肠病的方法。

USPTO Abstract

本发明提供介白素‑23受体的新颖肽抑制剂和相关组合物，以及使用这些肽抑制剂来治疗或预防多种疾病和病症，包括炎性肠病的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN115298196A
Jurisdiction: CN
Classification: —
Expires: 2022-11-04
Drug substance claim: No
Drug product claim: No
Assignee: Janssen Biotech Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.